SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors

BACKGROUND: Worse chemotherapy response for neurofibromatosis type 1- (NF1-) associated compared to sporadic malignant peripheral nerve sheath tumors (MPNST) has been reported. METHODS: We evaluated the objective response (OR) rate of patients with AJCC Stage III/IV chemotherapy-naive NF1 MPNST vers...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Sarcoma
Main Authors: Higham, Christine S., Steinberg, Seth M., Dombi, Eva, Perry, Arie, Helman, Lee J., Schuetze, Scott M., Ludwig, Joseph A., Staddon, Arthur, Milhem, Mohammed M., Rushing, Daniel, Jones, Robin L., Livingston, Michael, Goldman, Stewart, Moertel, Christopher, Wagner, Lars, Janhofer, David, Annunziata, Christina M., Reinke, Denise, Long, Lauren, Viskochil, David, Baker, Larry, Widemann, Brigitte C.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2017
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5613633/
https://ncbi.nlm.nih.gov/pubmed/29138631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8685638
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares